genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Skin diseases

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

Microbiome Therapeutics: Out of Range or Just Under the Radar?
Drug Discovery

Microbiome Therapeutics: Out of Range or Just Under the Radar?

StockWatch: MacroGenics Shares Crater after Trial Deaths
Drug Discovery

StockWatch: MacroGenics Shares Crater after Trial Deaths

Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders
Drug Discovery

Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders

Asia Pacific Startups Tackle Skin Disorders
Infectious Diseases

Asia Pacific Startups Tackle Skin Disorders

Culprit behind Psoriasis Revealed
News

Culprit behind Psoriasis Revealed

Taming the Immune System When Rare Diseases Strike
Drug Discovery

Taming the Immune System When Rare Diseases Strike

StockWatch: Nvidia Shares Leap Again after Reporting Record Revenues
Artificial Intelligence

StockWatch: Nvidia Shares Leap Again after Reporting Record Revenues

Going Small: Kymera’s Juliet Williams Touts Degrader Advantage in SLAS 2024 Keynote
Cancer

Going Small: Kymera’s Juliet Williams Touts Degrader Advantage in SLAS 2024 Keynote

StockWatch: Nvidia Jumps 24% on Recursion, Amgen AI Partnerships
Artificial Intelligence

StockWatch: Nvidia Jumps 24% on Recursion, Amgen AI Partnerships

123...24Page 1 of 24

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up